Morning Overview on MSN
How science and luck sparked a radical new era in schizophrenia treatment
The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...
MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the ...
The Centers for Medicare & Medicaid Services has announced new strategies to help decrease the inappropriate use of antipsychotic medication in nursing homes. Those include updates to the State ...
The importance of glutamate release modulation by evenamide used as an add-on therapy for patients with schizophrenia inadequately responding to their second-generation antipsychotics, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results